Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1

Status

Recruiting 81Active not recruiting 50Not yet recruiting 13Completed 6Suspended 5Withdrawn 4Terminated 3

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 8Lymphoid 5Genitourinary 5Gastrointestinal 4Sarcoma 3Myeloid 3CNS 3Breast 3Tumor-Agnostic 2Dermatologic 2Thoracic 1Plasma cell 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Lymphoma, Follicular 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1HTLV-I Infections 1Glioblastoma 1COVID-19 1Astrocytoma 1

Interventions

Cyclophosphamide 8Vincristine 7Prednisone 6Specimen Handling 5Rituximab 5Doxorubicin 5zanubrutinib 3prednylidene 3deltacortene 3Magnetic Resonance Spectroscopy 3tazemetostat 2fludarabine phosphate 2fludarabine 2Radiotherapy, Intensity-Modulated 2Melphalan 2Etoposide 2Drug Therapy 2CT-P10 2Biopsy 2Azacitidine 2Antibodies, Monoclonal 2vactosertib 1tisagenlecleucel 1sargramostim 1ponatinib 1pembrolizumab 1obinutuzumab 1mogamulizumab 1glucarpidase 1duvelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Suspended × Specimen Handling × Lymphoid × Clear all
NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 2 Suspended
80 enrolled
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04301076 2026-05-13

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

National Cancer Institute (NCI)

Phase 1 Suspended
30 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06860594 2026-05-13

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

National Cancer Institute (NCI)

Phase 1 Suspended
30 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT06575686 2026-01-21

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

City of Hope Medical Center

Phase 2 Suspended
33 enrolled
Lymphoid

Lymphoma, Follicular

NCT06639958 2025-08-29

A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home

Children's Oncology Group

Phase NA Suspended
64 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡